Back to Annual Meeting

Back to Annual Meeting

APHA Scientific Session and Event Listing

Luz Myriam Reynales-Shigematsu, MD, MSc¹, Sergio Arturo Juárez-Márquez, MD, FD¹, Raydel Valdés-Salgado, MSc², Eduardo Lazcano-Ponce, MD, MPH, ScD¹, and Maurico Hernandez-Avila, MD, ScD³. (1) National Institute of Public Health (INSP), Mexico, Av. Universidad 655, Cuernavaca, Morelos, Mexico, 52+777-329-3000, lreynales@insp.mx, (2) Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, W6027, Baltimore, MD 21205, (3) Director General, Instituto Nacional de Salud Pública, Av. Universidad 655, 3er. Piso, Cuernavaca, 62508, Mexico

Tobacco consumption is the principal modifiable risk factor causally associated with acute myocardial infarction (AMI). AMI has been an increasing and important cause of death in Mexico since 1980.

To estimate the direct health care costs of AMI, we carried out a cost of illness analysis, using data derived from an expert panel consensus and from medical chart review. We used the smoking attributable fraction (SAF) estimates to derive costs of tobacco consumption. We also estimated the benefits of a “Smoke-free workplaces” tobacco control policy in terms of avoidable deaths and health care costs savings.

We estimated an annual average costs of USD$6,420 and USD$9,216 for non-ST segment elevation AMI (NSTEMI) and ST segment elevation AMI (STEMI), respectively. The total annual health care costs estimated for incident AMI for the IMSS state-level division of Morelos reached USD$2.9 million, of which USD$1.6 million was directly attributed to tobacco consumption.

Our results confirm the high costs associated with smoking and show the potential benefits resulting from tobacco control policy.

Learning Objectives:

1.Describe the methodology used to estimate the medical costs associated with tobacco related myocardial infarction in Mexico. 2.Discuss the health costs saving of smoke-free workplaces.
• Discuss the science-policy interface and how Mexico can use this type of research to further their tobacco control policy agenda.

Keywords: Tobacco, Myocardial Infarction

Presenting author's disclosure statement:

Not Answered